Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
5.040
+0.450 (+9.80%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Geron Corp
< Previous
1
2
3
4
5
Next >
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
January 11, 2023
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million
January 10, 2023
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
January 05, 2023
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Proposed Public Offering of Common Stock
January 04, 2023
From
Geron Corporation
Via
Business Wire
Geron (NASDAQ: GERN) Reports Positive Results From IMerge Phase 3 Trial of Imetelstat for Lower Risk MDS
January 04, 2023
Geron Corporation (NASDAQ: GERN) is engaged as a late-stage biopharmaceutical company, which is focused on the research and development of
Via
Spotlight Growth
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS
January 04, 2023
From
Geron Corporation
Via
Business Wire
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3
January 03, 2023
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients
December 12, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2022
From
Geron Corporation
Via
Business Wire
Geron to Participate in Stifel 2022 Healthcare Conference
November 07, 2022
From
Geron Corporation
Via
Business Wire
Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS
November 03, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
November 03, 2022
From
Geron Corporation
Via
Business Wire
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
October 27, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
September 08, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at Upcoming Investor Conferences
September 01, 2022
From
Geron Corporation
Via
Business Wire
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
August 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Second Quarter 2022 Financial Results
August 11, 2022
From
Geron Corporation
Via
Business Wire
Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022
August 04, 2022
From
Geron Corporation
Via
Business Wire
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
August 03, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Expansion of Existing Loan Facility
June 30, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
June 15, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports First Quarter 2022 Financial Results
May 09, 2022
From
Geron Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.